Study CHAMPIONs cangrelor antiplatelet

The fast-acting antiplatelet agent cangrelor significantly reduces the risk for ischemic events, including stent thrombosis, in patients during percutaneous coronary intervention, without significantly increasing severe bleeding, researchers report.
Source: MedWire News - Cardiology - Category: Cardiology Source Type: news